Katherine Labella
Impact in
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
-
- Cytokine Signaling Pathways and Interactions
Papers in
-
- Protein Degradation and Inhibitors 2
- FOXO transcription factor regulation 1
-
- Prostate Cancer Treatment and Research 1
- Co-authors
- Suhu Liu (2 shared papers)David A. Frank (2 shared papers)Thomas Look (1 shared paper)Li Tan (1 shared paper)Scott B. Ficarro (1 shared paper)Koshi Akahane (1 shared paper)Esra A. Akbay (1 shared paper)Kathleen M. S. E. Reyskens (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (1 paper)Blood Advances (1 paper)PLoS ONE (1 paper)Cancer Research (1 paper)Journal of Visualized Experiments (1 paper)
- Partner nations
- United States
In The Last Decade
Katherine Labella
5 papers receiving 139 citations
Peers
Comparison fields: 5 of 35
- Genetics 34
- Oncology 68
- Pharmacology 16
- Hematology 13
- Immunology 24
Countries citing papers authored by Katherine Labella
This map shows the geographic impact of Katherine Labella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Labella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Labella more than expected).
Fields of papers citing papers by Katherine Labella
This network shows the impact of papers produced by Katherine Labella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Labella. The network helps show where Katherine Labella may publish in the future.
Co-authors
The 25 scholars most cited alongside Katherine Labella, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 87 | |
| 2 | 2016 | 30 | |
| 3 | 2018 | 22 | |
| 4 | 2023 | 2 | |
| 5 | 2024 | 1 |
About Katherine Labella
Katherine Labella is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Genetics and Neurology, having authored 5 papers that have together received 142 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (2 papers), interferon and immune responses (1 paper), Pharmacological Effects of Natural Compounds (1 paper), FOXO transcription factor regulation (1 paper), Estrogen and related hormone effects (1 paper), Prostate Cancer Treatment and Research (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). The work is most often cited by research in Genetics (34 citations), Oncology (68 citations), Pharmacology (16 citations), Hematology (13 citations) and Immunology (24 citations). Katherine Labella has collaborated with scholars based in United States. Frequent co-authors include Suhu Liu, David A. Frank, Thomas Look, Li Tan, Scott B. Ficarro, Koshi Akahane, Esra A. Akbay, Kathleen M. S. E. Reyskens, Shohei Koyama and Liv Johannessen. Their work appears in journals such as Journal of Medicinal Chemistry, Blood Advances, PLoS ONE, Cancer Research and Journal of Visualized Experiments.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.